Kim Helen Susan — SEC Form 4 filings

SEC reporting owner CIK 1422772. 3 Form 4 filings on record with FilingPulse; latest filed 2026-01-12.

Transaction summary — filings shown

Covers all 3 filings on record, filed 2024-05-17 to 2026-01-12. Counts and totals are arithmetic on values as filed — descriptive data, not a recommendation.

By issuer — same filings

Open-market purchase/sale legs on non-derivative securities, grouped by issuer. Role is as filed on the newest filing for that issuer. Dollar totals cover priced legs only (shares × price as filed). Ordered by priced transaction value, largest first.

IssuerRole (as filed)FilingsPurchases (P)Sales (S)Other legs
Aktis Oncology, Inc. (AKTS)Director, 10% owner12 legs · 835,000 sh · $15,030,0006
PROTHENA CORP PUBLIC LTD CO (PRTA)Director22

Form 4 filings — Kim Helen Susan

FiledFormIssuerReported transactionsSource
2026-01-124Aktis Oncology, Inc. (AKTS)Conversion (C): 4,859,370 · Purchase (P): 812,455 @ $18 · Conversion (C): 134,842 · Purchase (P): 22,545 @ $18 · Conversion (C): 14,838,250 (derivative) @ $0 · Conversion (C): 411,750 (derivative) @ $0 · +2 moreEDGAR
2025-05-164PROTHENA CORP PUBLIC LTD CO (PRTA)Grant/award (A): 20,183 (derivative) @ $0EDGAR
2024-05-174PROTHENA CORP PUBLIC LTD CO (PRTA)Grant/award (A): 15,000 (derivative) @ $0EDGAR

FilingPulse's Form 4 archive currently extends back to 2024-01-11 and is expanding backward through EDGAR history — earlier filings by this insider may not be indexed yet. Names and roles are shown as filed.

Need this as JSON? GET https://api.filingpulse.io/v1/insider-trades?owner_cik=1422772 returns every filing on this page — normalized, with footnotes and derivative legs — and webhooks push new filings to you in seconds. API docs →